Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-15

FDA Approved: AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for a fixed-dose combination of amlodipine and benazepril hydrochloride manufactured by Rising Pharma Holdings, Inc. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine and Benazepril Hydrochloride (Amlodipine and Benazepril Hydrochloride)

Snippet

SUPPL AP for AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE (AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE)